Reductions in Insulin Resistance are Mediated Primarily via Weight Loss in Subjects With Type 2 Diabetes on Semaglutide.

Fonseca, Vivian A; Capehorn, Matthew S; Garg, Satish K; Jódar Gimeno, Esteban; Hansen, Oluf H; Holst, Anders G; Nayak, Gurudutt; Seufert, Jochen

Fonseca, Vivian A; Capehorn, Matthew S; Garg, Satish K; Jódar Gimeno, Esteban; Hansen, Oluf H; Holst, Anders G; Nayak, Gurudutt; Seufert, Jochen.

Afiliação

Fonseca VA; Health Sciences Center, Tulane University, New Orleans, Louisiana.
Capehorn MS; Rotherham Institute for Obesity, Clifton Medical Centre, Rotherham, United Kingdom.
Garg SK; Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado.
Jódar Gimeno E; Hospital Universitario Quirón Salud Madrid, Universidad Europea de Madrid, Madrid, Spain.
Hansen OH; Novo Nordisk A/S, Søborg, Denmark.
Holst AG; Novo Nordisk A/S, Søborg, Denmark.
Nayak G; Novo Nordisk A/S, Søborg, Denmark.
Seufert J; University of Freiburg Medical Center, Medical Faculty, University of Freiburg, Freiburg, Germany.

J Clin Endocrinol Metab ; 104(9): 4078-4086, 2019 Sep 01.

Article em En | MEDLINE | ID: mdl-30938762

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2019 Tipo de documento: Article